Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput screening in the diagnostics industry.

S Wilson1, S Howell

  • 1Unipath Ltd., Priory Business Park, Bedford MK44 3UP, UK.

Biochemical Society Transactions
|August 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a needs-based model of care on the characteristics of healthcare services in England: the i-THRIVE National Implementation Programme.

Epidemiology and psychiatric sciences·2025
Same author

Appreciating the links between heart failure and depression.

QJM : monthly journal of the Association of Physicians·2023
Same author

The Routine Clinical Implementation of Electronic Patient-reported Outcome Measures (ePROMs) at The Christie NHS Foundation Trust.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same author

Ultrasound-guided continuous transmuscular quadratus lumborum block- L4 or L2 level catheter insertion for analgesia in open abdominal surgery: Case series.

Indian journal of anaesthesia·2018
Same author

Intravenous tranexamic acid and lower limb arthroplasty-a randomised controlled feasibility study.

Anaesthesia and intensive care·2018
Same author

Paediatric antiepileptic polytherapy: systematic review of efficacy and neurobehavioural effects and a tertiary centre experience.

Acta paediatrica (Oslo, Norway : 1992)·2018
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles

High-throughput screening accelerates diagnostics development by rapidly identifying optimal antibody pairs for lateral-flow immuno-diagnostics. This innovation significantly shortens product development cycles, enabling faster market entry for new diagnostic tools.

Area of Science:

  • Biotechnology
  • Immunodiagnostics
  • Assay Development

Background:

  • The diagnostics industry faces pressure to accelerate product development cycles.
  • Efficient screening of reagents is crucial for rapid innovation in diagnostics.

Purpose of the Study:

  • To highlight the application of high-throughput screening in accelerating the product development cycle for diagnostics.
  • To emphasize the importance of rapid antibody pair selection for lateral-flow immuno-diagnostics.

Main Methods:

  • Utilizing surface plasmon resonance biosensors (e.g., Biacore) for rapid antibody pairing evaluation.
  • Employing automated screening systems (e.g., DELFIA) for processing large test volumes.
  • Leveraging robotics for automating routine product testing.

Related Experiment Videos

Main Results:

  • Surface plasmon resonance biosensors can evaluate over 400 antibody pairings in under 5 days.
  • Conventional methods for screening antibody pairs take many months.
  • Automated systems and robotics significantly reduce product development timelines.

Conclusions:

  • High-throughput screening methods drastically shorten the time required for antibody reagent selection.
  • Accelerated screening processes are essential for meeting market demands in the diagnostics industry.
  • The integration of automated technologies streamlines the entire product development lifecycle.